NF + SWN Diagnosis
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
The Children’s Tumor Foundation NF + SWN Diagnosis App is designed to support healthcare providers as a useful tool for diagnosing patients who may have neurofibromatosis type 1 or a type of schwannomatosis (collectively referred to as NF) or a related disorder. With a special focus on the 2021 and 2022 updates to the diagnostic criteria, the app compiles the most relevant, evidence-based clinical guidelines from multiple sources into a single tool and places them at the clinician’s fingertips.
This free app was created by the Children’s Tumor Foundation as a tool for medical professionals, clinicians, genetic counselors, medical students, and general practitioners.
About Children’s Tumor Foundation
Founded in 1978, the Children’s Tumor Foundation (CTF) began as the first grassroots organization solely dedicated to finding treatments for all types of NF. Today, CTF is a highly recognized global nonprofit foundation, the leading force in the fight to end NF, and a model for other innovative research endeavors.
Our Mission: Drive research, expand knowledge, and advance care for the NF community.
Our Vision: End NF.
Only a medical professional can confirm a diagnosis of NF1, Legius Syndrome, or any type of schwannomatosis (including NF2-related schwannomatosis, formerly called NF2). This mobile app is a tool and not a replacement for diagnostic assessment and medical management from a healthcare provider.
Hide..
Show more..
This free app was created by the Children’s Tumor Foundation as a tool for medical professionals, clinicians, genetic counselors, medical students, and general practitioners.
About Children’s Tumor Foundation
Founded in 1978, the Children’s Tumor Foundation (CTF) began as the first grassroots organization solely dedicated to finding treatments for all types of NF. Today, CTF is a highly recognized global nonprofit foundation, the leading force in the fight to end NF, and a model for other innovative research endeavors.
Our Mission: Drive research, expand knowledge, and advance care for the NF community.
Our Vision: End NF.
Only a medical professional can confirm a diagnosis of NF1, Legius Syndrome, or any type of schwannomatosis (including NF2-related schwannomatosis, formerly called NF2). This mobile app is a tool and not a replacement for diagnostic assessment and medical management from a healthcare provider.
Screenshots
User Rating
0 out of 5
0 ratings in Australia
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
Adolescent Job Aid
|
0
|
2 years ago | |
Albatross Care
Long Reach Medicine
|
0
|
1 year ago | |
N/A/
Cancer Surveillance
|
0
|
2 years ago | |
LEDD Calculator
Levodopa Equivalent Daily Dose
|
0
|
2 years ago | |
SAMS DHS
|
0
|
1 year ago | |
PediQUEST
For patients and families
|
0
|
2 months ago | |
Multiple Myeloma Management
|
0
|
1 year ago | |
OnTheBit
|
0
|
2 years ago | |
Atlas Muay Thai Gym
|
0
|
1 month ago | |
Gather-ed
Small group social learning
|
0
|
3 weeks ago |
Show More
Revenue and Downloads
Gain valuable insights into NF + SWN Diagnosis performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Children's Tumor Foundation
- Languages
- English
- Recent version
- 1.4 (4 months ago )
- Released on
- Sep 27, 2022 (1 year ago )
- Also available in
- New Zealand, Israel, India, Argentina, Japan, South Korea, Kuwait, Mexico, Malaysia, Netherlands, Italy, Peru, Philippines, Pakistan, Poland, Romania, Singapore, Turkey, United States, Vietnam, Austria, Belarus, Czechia, Dominican Republic, Algeria, Ecuador, Spain, Finland, United Kingdom, Greece, Australia, Azerbaijan, Ukraine, Belgium, Sweden, Denmark, Saudi Arabia, Russia, Colombia, Ireland, Kazakhstan, France, Hong Kong, Hungary
- Last updated
- 2 months ago